Skip to main content

Receptor internalization

pharmacology

The withdrawal of receptors from the cell surface into the interior of the cell after sustained or beta-arrestin-biased agonist activity. It puts receptors out of reach of the drug and is the molecular basis of tachyphylaxis — tolerance appearing within a single exposure — and is distinct from downregulation, which reduces how many receptors the cell makes.

Receptor internalization (also spelled internalisation) is the process by which a cell withdraws active receptors from its surface into its interior, temporarily placing them beyond reach of drug molecules in the bloodstream. It is a form of desensitisation, and distinct from downregulation: downregulation reduces how many receptors a cell produces; internalization removes those that already exist from the membrane.

The process is mediated by a family of proteins called beta-arrestins, which bind to phosphorylated receptors and recruit the molecular machinery of endocytosis to pull receptor-bearing membrane inward into vesicles.

How it works · its role

When a receptor is activated repeatedly — or by certain agonists that strongly recruit beta-arrestin — kinases attach phosphate groups to its inner surface. Beta-arrestin recognises this tag, binds, and does two things simultaneously: it uncouples the receptor from its downstream G protein, ending the active signal, and recruits the machinery of clathrin-mediated endocytosis.

The receptor is then packaged into a vesicle and moved into the cell interior. Once inside, it faces a fork: it can be recycled back to the surface, restoring sensitivity, or trafficked to lysosomes and degraded. The balance between these fates determines whether tolerance is brief or more durable.

Relevance to substances & effects

Receptor internalization is most directly relevant to drugs acting on G protein-coupled receptors — opioids, cannabinoids, dopaminergic drugs, and many serotonergic compounds. Different opioids vary considerably in how strongly they drive internalization of the μ-opioid, and these differences are thought to contribute to variation in tolerance profiles across the class.

The concept also underpins biased agonism: some drugs preferentially activate G protein signalling while producing little beta-arrestin recruitment; others do the reverse. This asymmetry is pharmacologically significant because the two arms of the receptor's response can be separated by the right ligand.

Tolerance & dependence

Receptor internalization is the primary molecular mechanism of tachyphylaxis — rapid tolerance that can appear within a single exposure. A drug used repeatedly over several hours may produce noticeably diminished effects toward the end of that session, because a substantial fraction of its receptors have moved into the cell interior.

This form of tolerance is generally shorter-lived than tolerance built through downregulation. As the drug clears and the drive to internalize fades, many receptors recycle to the surface and sensitivity partially restores. How quickly this happens depends on the balance between receptor recycling and degradation — and on which receptor populations are affected.

AI-generated · not yet verified by a human reviewer

Harm-reduction reference — not medical advice.

Last updated Aug 24, 2026Report an issue